Pearls and perils in the management of germ cell tumors

Cynthia X Wei1, Lawrence H Einhorn, Nabil Adra

  • 1Division of Hematology and Medical Oncology - Melvin and Bren Simon Cancer Center, Indiana University School of Medicine, Indianapolis, Indiana, USA.

Current Opinion in Oncology
|February 12, 2021
PubMed
Abstract

Insights

Testicular cancer (germ cell tumors) is highly curable, but challenges persist in treatment, surveillance, and long-term care for survivors. This review addresses these complex management aspects and offers insights for improved patient outcomes.

Area of Science:

  • Oncology
  • Urology

Background:

  • Testicular cancer, or germ cell tumors (GCT), has seen significant advancements making it highly curable.
  • Despite progress, complex challenges persist in managing GCT patients and survivors.

Purpose of the Study:

  • To review current challenges in testicular cancer (GCT) management and surveillance.
  • To highlight pearls and perils in GCT patient care, focusing on treatment, tumor marker interpretation, and long-term survivorship.

Main Methods:

  • Literature review of current research and emerging data in GCT management.
  • Synthesis of institutional knowledge and expert opinion on challenging clinical scenarios.

Main Results:

  • Uncertainties exist in first-line and salvage GCT treatments.
  • Complexities arise in interpreting tumor markers (AFP, hCG) and managing supportive therapies.
  • Long-term effects of surgery and chemotherapy on survivors require continued attention.

Conclusions:

  • Testicular cancer management presents ongoing clinical challenges.
  • Addressing these complexities is crucial for optimizing patient outcomes and survivorship.
  • This review provides insights into navigating difficult aspects of GCT care.